Stay updated on ACTT: Remdesivir for Severe COVID-19 Clinical Trial

Sign up to get notified when there's something new on the ACTT: Remdesivir for Severe COVID-19 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ACTT: Remdesivir for Severe COVID-19 Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2.
    Difference
    0.0%
    Check dated 2026-02-14T04:47:28.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision updated: added v3.4.1 and removed v3.4.0.
    Difference
    0.0%
    Check dated 2026-02-06T20:41:05.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    Added Show glossary and Hide glossary controls and updated revision metadata to Revision: v3.4.0 and Last Update Submitted that Met QC Criteria, replacing the previous labels (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4).
    Difference
    0.2%
    Check dated 2026-01-23T18:19:03.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Added Revision: v3.3.4 and removed Revision: v3.3.3 from the page's revision history.
    Difference
    0.0%
    Check dated 2026-01-16T12:10:38.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    The Locations section was updated with new site entries (US states and international locations) and the removal of several previously listed sites. A new revision tag Revision: v3.3.3 appears to accompany the changes.
    Difference
    2%
    Check dated 2025-12-18T23:06:05.000Z thumbnail image
  7. Check
    93 days ago
    Change Detected
    Summary
    Publications are described as automatically filled from PubMed, and a Revision: v3.3.2 note was added. These edits are editorial and do not affect the study content or participation details.
    Difference
    0.1%
    Check dated 2025-11-27T04:28:17.000Z thumbnail image

Stay in the know with updates to ACTT: Remdesivir for Severe COVID-19 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ACTT: Remdesivir for Severe COVID-19 Clinical Trial page.